Tag : OffLabel

Neurology

FDA Warns of Stroke, Death With Off-Label Use of Wingspan Stent

Newsemia
Postmarket data show a significantly increased risk of stroke or death when the Wingspan intracranial stent system is used outside the approved indications. News Alerts...
Latest News

Global Myelofibrosis Therapeutics Market 2018-2022| High Off-Label Prescription to Boost Demand | Technavio

Newsemia
LONDON–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/MyelofibrosisTherapeutics?src=hash" target="_blank"gt;#MyelofibrosisTherapeuticslt;/agt;–The global myelofibrosis therapeutics market is expected to post a CAGR of over 7% during 2018-2022, according to Technavio's latest market research....
Neurology

Off-Label Drug Research Generates 'Medical Uncertainty'

Newsemia
Research that explores/supports off-label use of pregabalin and other medications may be misleading if early promising results are not subsequently validated, investigators suggest in a...
Cardiology

Initial results from the off-label use of the SAPIEN S3 valve for percutaneous transcatheter pulmonary valve replacement: A multi-institutional experience.

Newsemia
Related Articles Initial results from the off-label use of the SAPIEN S3 valve for percutaneous transcatheter pulmonary valve replacement: A multi-institutional experience. Catheter Cardiovasc Interv....

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy